pfizer

US shares closed decrease for a second straight session on Tuesday after information indicating that the labor market remained on stable floor dimmed hopes the Federal Reserve may need sufficient cause to start decreasing the scale of…

Pfizer Inc expects to roughly quadruple the worth of its COVID-19 vaccine to about $110 to $130 per dose after the US authorities's present buy program expires, Pfizer govt Angela Lukin mentioned on Thursday. Lukin mentioned she expects…

Mumbai: Pharma was usually handed over by traders in search of multi-bagger returns when cash was low-cost and shares have been surging. However now the pocket, bracketed as a defensive play in opposition to the vagaries of world macros,…